Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Pfizer
Pfizer
Second Life Therapeutics
Technische Universität Dresden
Shanghai Weihe Medical Laboratory Co., Ltd.
Anhui Provincial Hospital
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's